Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis Axel U. Dignass, Bernd Bokemeyer, Henning Adamek, Michael Mross, Lars Vinter-Jensen, Norbert Börner, Jouni Silvennoinen, Gie Tan, Marco Oudkerk Pool, Theo Stijnen, Peter Dietel, Tobias Klugmann, Severine Vermeire, Aomesh Bhatt, Henri Veerman Clinical Gastroenterology and Hepatology Volume 7, Issue 7, Pages 762-769 (July 2009) DOI: 10.1016/j.cgh.2009.04.004 Copyright © 2009 AGA Institute Terms and Conditions
Figure 1 Schematic representation of patient flow and reasons for discontinuation. Clinical Gastroenterology and Hepatology 2009 7, 762-769DOI: (10.1016/j.cgh.2009.04.004) Copyright © 2009 AGA Institute Terms and Conditions
Figure 2 Kaplan–Meier estimated UC-DAI remission rates, where remission is defined as a UC-DAI total score <2. Clinical Gastroenterology and Hepatology 2009 7, 762-769DOI: (10.1016/j.cgh.2009.04.004) Copyright © 2009 AGA Institute Terms and Conditions